Related Experiment Video
Updated: Jun 20, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Postgraduate education for doctors in smoking cessation
Nicholas A Zwar1, Robyn L Richmond, David Davidson
1School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia. n.zwar@unsw.edu.au
Drug and Alcohol Review
|September 10, 2009
Summary
Postgraduate smoking cessation education for doctors is inconsistent and has limited reach. New strategies are needed to improve the availability and uptake of these vital training programs for healthcare professionals.
Area of Science:
- Medical Education
- Public Health
- Tobacco Control
Background:
- Physician-delivered smoking cessation advice improves quit rates but is often missed.
- Postgraduate education is a key strategy to enhance smoking cessation support.
- This study examines existing postgraduate training programs for doctors.
Purpose of the Study:
- To describe current postgraduate education programs for doctors in smoking cessation.
- To identify future directions for improving the reach and quality of such programs.
Main Methods:
- Survey of key informants identified via tobacco control listserves.
- Literature review of education programs published since 2000 (excluding Europe).
Main Results:
- Limited number of programs identified (21 key informants, 2 from literature).
- Common program components include the 5 As approach, stage of change, motivational interviewing, and pharmacotherapies.
- High adherence to clinical practice guidelines (84%); face-to-face delivery most common.
- Barriers: lack of doctor interest and funding.
Conclusions:
- Program identification was challenging, revealing limited reach.
- Consistent program content and strong links to guidelines were noted.
- Novel approaches are essential to increase the availability and adoption of smoking cessation postgraduate education.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...